Jemma M. Boyle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jemma M. Boyle has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
Jan van der Meulen
National Cancer Audit Collaborating Centre, Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK; Department of Health Services Research & Policy, London School of Hygiene & Tropical Medicine, London, UK
7 shared publications- Angela Kuryba
Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK
6 shared publications Kate Walker
Department of Health Services Research and Policy London School of Hygiene and Tropical Medicine London UK
6 shared publicationsMichael S. Braun
Department of Oncology The Christie NHS Foundation Trust Manchester UK
6 shared publicationsNicola S. Fearnhead
6 shared publicationsAjay Aggarwal
National Cancer Audit Collaborating Centre, Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK; Department of Health Services Research & Policy, London School of Hygiene & Tropical Medicine, London, UK; Guy's Cancer Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK
5 shared publications
Latest Publications
- Open Access
How representative are responders to the english cancer patient experience survey of english breast cancer patients? A cohort study using linked national cancer patient experience survey and cancer registry data
Objective The annual National Cancer Patient Experience Survey (CPES) gives insights into the quality of care received by patients with cancer treated in the NHS. This study assesses how the sample of breast cancer (BC) patients who responded to CPES in England compares to the population diagnosed with breast cancer. Design Retrospective population-based cohort study, conducted as part of the National Audit of Primary Breast Cancer and the National Audit of Metastatic Breast Cancer. Setting National Cancer Patient Experience Survey (CPES) responses linked to National Cancer Registration data for BC patients (stage 0–4) diagnosed between 2015 and 2021. Participants 315 676 people diagnosed with BC 2015–2021. Primary and secondary outcome measures Logistic regression was used to assess the association between personal, disease, and clinical characteristics and the odds of responding to CPES. Results CPES responses were provided by 44 809 individuals,14.2% of breast cancer registration records. Most survey responses (69%) were from patients in their first year since diagnosis. Response rates were significantly lower among men (adjusted odds ratio (aOR) 0.79; CI 0.68 to 0.92; p=0.002), younger (18–39 years, aOR 0.51; CI 0.48 to 0.54; 9Conclusion People with breast cancer who return CPES questionnaires differ in their characteristics to the population of people diagnosed with breast cancer. CPES is a valuable tool for supporting quality improvement, but this study highlights the need for targeted strategies to increase participation among underrepresented groups.
Open AccessHow representative are responders to the english cancer patient experience survey of english breast cancer patients? A cohort study using linked national cancer patient experience survey and cancer registry data
Objective The annual National Cancer Patient Experience Survey (CPES) gives insights into the quality of care received by patients with cancer treated in the NHS. This study assesses how the sample of breast cancer (BC) patients who responded to CPES in England compares to the population diagnosed with breast cancer. Design Retrospective population-based cohort study, conducted as part of the National Audit of Primary Breast Cancer and the National Audit of Metastatic Breast Cancer. Setting National Cancer Patient Experience Survey (CPES) responses linked to National Cancer Registration data for BC patients (stage 0–4) diagnosed between 2015 and 2021. Participants 315 676 people diagnosed with BC 2015–2021. Primary and secondary outcome measures Logistic regression was used to assess the association between personal, disease, and clinical characteristics and the odds of responding to CPES. Results CPES responses were provided by 44 809 individuals,14.2% of breast cancer registration records. Most survey responses (69%) were from patients in their first year since diagnosis. Response rates were significantly lower among men (adjusted odds ratio (aOR) 0.79; CI 0.68 to 0.92; p=0.002), younger (18–39 years, aOR 0.51; CI 0.48 to 0.54; 9Conclusion People with breast cancer who return CPES questionnaires differ in their characteristics to the population of people diagnosed with breast cancer. CPES is a valuable tool for supporting quality improvement, but this study highlights the need for targeted strategies to increase participation among underrepresented groups.
- Open Access
- 11 July 2026
- Published by Elsevier in eClinicalMedicine
- Vol. 97
Clinicopathological, multimodal treatment, and survival patterns for men with breast cancer in England and Wales: a population-based cohort study
- 11 July 2026
- Published by Elsevier in eClinicalMedicine
- Vol. 97
Open AccessClinicopathological, multimodal treatment, and survival patterns for men with breast cancer in England and Wales: a population-based cohort study
- Open Access
- 15 May 2026
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 137 (1) , 210-222
Decision-making processes in older patients that require, but do not undergo, emergency laparotomy in the UK: a multicentre observational study
- 15 May 2026
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 137 (1) , 210-222
Open AccessDecision-making processes in older patients that require, but do not undergo, emergency laparotomy in the UK: a multicentre observational study
- Open Access
Age, patient experience and satisfaction with breast cancer care: a cohort study using linked national cancer patient experience survey and cancer registry data
Objective To examine whether satisfaction with information provision and involvement in decision-making among people with breast cancer (BC) treated in English hospitals was associated with age and other patient characteristics. Design Retrospective population-based cohort study, conducted as part of the National Audit of Primary Breast Cancer and the National Audit of Metastatic Breast Cancer. Setting National Cancer Patient Experience Survey (CPES) responses linked to National Cancer Registration data for BC patients (stage 0–4) diagnosed between 2017 and 2021. Participants 40 018 patients diagnosed with BC who responded to CPES between 2017 and 2021. Primary and secondary outcome measures Responses to questions about overall experience of care, satisfaction with information provision, involvement in decision-making and clinical nurse specialist (CNS) contact were examined. The relationships between responses, personal, disease and clinical characteristics were analysed using multivariable Poisson regression. Results 90% of patients rated their overall care as ≥8 out of 10 (0=very poor; 10=very good), decreasing to 82% for those aged Conclusion Most patients reported high satisfaction with their BC care. Satisfaction was consistently lower among younger people and those with advanced disease; this finding might partly reflect more complex pathways but requires further exploration, ideally in partnership with patients to codesign solutions. Actionable remedial strategies are proposed.
Open AccessAge, patient experience and satisfaction with breast cancer care: a cohort study using linked national cancer patient experience survey and cancer registry data
Objective To examine whether satisfaction with information provision and involvement in decision-making among people with breast cancer (BC) treated in English hospitals was associated with age and other patient characteristics. Design Retrospective population-based cohort study, conducted as part of the National Audit of Primary Breast Cancer and the National Audit of Metastatic Breast Cancer. Setting National Cancer Patient Experience Survey (CPES) responses linked to National Cancer Registration data for BC patients (stage 0–4) diagnosed between 2017 and 2021. Participants 40 018 patients diagnosed with BC who responded to CPES between 2017 and 2021. Primary and secondary outcome measures Responses to questions about overall experience of care, satisfaction with information provision, involvement in decision-making and clinical nurse specialist (CNS) contact were examined. The relationships between responses, personal, disease and clinical characteristics were analysed using multivariable Poisson regression. Results 90% of patients rated their overall care as ≥8 out of 10 (0=very poor; 10=very good), decreasing to 82% for those aged Conclusion Most patients reported high satisfaction with their BC care. Satisfaction was consistently lower among younger people and those with advanced disease; this finding might partly reflect more complex pathways but requires further exploration, ideally in partnership with patients to codesign solutions. Actionable remedial strategies are proposed.
- 31 January 2026
- Published by Elsevier in Clinical Oncology
- Vol. 52, 104070
The National Audit of Metastatic Breast Cancer (NAoMe): Sharing Key Findings and Recommendations From the 2025 State of the Nation Report
- 31 January 2026
- Published by Elsevier in Clinical Oncology
- Vol. 52, 104070
The National Audit of Metastatic Breast Cancer (NAoMe): Sharing Key Findings and Recommendations From the 2025 State of the Nation Report
- Open Access
- 4 October 2024
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 133 (5) , 973-982
Characterisation of older patients that require, but do not undergo, emergency laparotomy: a multicentre cohort study
- 4 October 2024
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 133 (5) , 973-982
Open AccessCharacterisation of older patients that require, but do not undergo, emergency laparotomy: a multicentre cohort study
- Open Access
- 1 February 2024
- Published by Wiley in Colorectal Disease
- Vol. 26 (3) , 486-496
Inequalities in the recovery of colorectal cancer services during the COVID ‐19 pandemic: a national population‐based study
Aim: Evidence is lacking on whether there were inequalities in the recovery of colorectal cancer (CRC) services within the English National Health Service (NHS) following the COVID‐19 pandemic. The aim of this study was to evaluate recovery according to patient age and socioeconomic status. Method: Using routinely collected data, CRC patients diagnosed and treated in the English NHS were identified for two timeframes: the ‘initial pandemic period’ (April–June 2020) and the ‘pandemic period’ (April 2020–March 2022). Poisson models evaluated changes in numbers of diagnoses, major resections, adjuvant chemotherapy and neoadjuvant radiotherapy use for each timeframe, relative to the equivalent pre‐pandemic timeframe (April–June 2019 and April 2018–March 2020, respectively), stratified by age and socioeconomic status. Tumour stage at presentation was evaluated over time. Results: Substantial deficits in diagnoses, major resections and adjuvant chemotherapy were identified in the initial pandemic period, whilst the use of neoadjuvant radiotherapy increased. Overall, these deficits recovered. Patients outside screening age, and in the most deprived group, had greater deficits in diagnoses and major resections. There was no evidence of stage migration by June 2021. Conclusions: CRC services showed recovery to baseline during the pandemic. However, evident inequalities must be addressed in ongoing recovery efforts. Long‐term outcomes will fully establish the impact of the pandemic on CRC patients.
- 1 February 2024
- Published by Wiley in Colorectal Disease
- Vol. 26 (3) , 486-496
Open AccessInequalities in the recovery of colorectal cancer services during the COVID ‐19 pandemic: a national population‐based study
Aim: Evidence is lacking on whether there were inequalities in the recovery of colorectal cancer (CRC) services within the English National Health Service (NHS) following the COVID‐19 pandemic. The aim of this study was to evaluate recovery according to patient age and socioeconomic status. Method: Using routinely collected data, CRC patients diagnosed and treated in the English NHS were identified for two timeframes: the ‘initial pandemic period’ (April–June 2020) and the ‘pandemic period’ (April 2020–March 2022). Poisson models evaluated changes in numbers of diagnoses, major resections, adjuvant chemotherapy and neoadjuvant radiotherapy use for each timeframe, relative to the equivalent pre‐pandemic timeframe (April–June 2019 and April 2018–March 2020, respectively), stratified by age and socioeconomic status. Tumour stage at presentation was evaluated over time. Results: Substantial deficits in diagnoses, major resections and adjuvant chemotherapy were identified in the initial pandemic period, whilst the use of neoadjuvant radiotherapy increased. Overall, these deficits recovered. Patients outside screening age, and in the most deprived group, had greater deficits in diagnoses and major resections. There was no evidence of stage migration by June 2021. Conclusions: CRC services showed recovery to baseline during the pandemic. However, evident inequalities must be addressed in ongoing recovery efforts. Long‐term outcomes will fully establish the impact of the pandemic on CRC patients.
- Open Access
- 29 January 2024
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (3) , 1564-1576
Improving risk models for patients having emergency bowel cancer surgery using linked electronic health records: a national cohort study
Background: Life-saving emergency major resection of colorectal cancer (CRC) is a high-risk procedure. Accurate prediction of postoperative mortality for patients undergoing this procedure is essential for both healthcare performance monitoring and preoperative risk assessment. Risk-adjustment models for CRC patients often include patient and tumour characteristics, widely available in cancer registries and audits. The authors investigated to what extent inclusion of additional physiological and surgical measures, available through linkage or additional data collection, improves accuracy of risk models. Methods: Linked, routinely-collected data on patients undergoing emergency CRC surgery in England between December 2016 and November 2019 were used to develop a risk model for 90-day mortality. Backwards selection identified a ‘selected model’ of physiological and surgical measures in addition to patient and tumour characteristics. Model performance was assessed compared to a ‘basic model’ including only patient and tumour characteristics. Missing data was multiply imputed. Results: Eight hundred forty-six of 10 578 (8.0%) patients died within 90 days of surgery. The selected model included seven preoperative physiological and surgical measures (pulse rate, systolic blood pressure, breathlessness, sodium, urea, albumin, and predicted peritoneal soiling), in addition to the 10 patient and tumour characteristics in the basic model (calendar year of surgery, age, sex, ASA grade, TNM T stage, TNM N stage, TNM M stage, cancer site, number of comorbidities, and emergency admission). The selected model had considerably better discrimination compared to the basic model (C-statistic: 0.824 versus 0.783, respectively). Conclusion: Linkage of disease-specific and treatment-specific datasets allowed the inclusion of physiological and surgical measures in a risk model alongside patient and tumour characteristics, which improves the accuracy of the prediction of the mortality risk for CRC patients having emergency surgery. This improvement will allow more accurate performance monitoring of healthcare providers and enhance clinical care planning.
- 29 January 2024
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (3) , 1564-1576
Open AccessImproving risk models for patients having emergency bowel cancer surgery using linked electronic health records: a national cohort study
Background: Life-saving emergency major resection of colorectal cancer (CRC) is a high-risk procedure. Accurate prediction of postoperative mortality for patients undergoing this procedure is essential for both healthcare performance monitoring and preoperative risk assessment. Risk-adjustment models for CRC patients often include patient and tumour characteristics, widely available in cancer registries and audits. The authors investigated to what extent inclusion of additional physiological and surgical measures, available through linkage or additional data collection, improves accuracy of risk models. Methods: Linked, routinely-collected data on patients undergoing emergency CRC surgery in England between December 2016 and November 2019 were used to develop a risk model for 90-day mortality. Backwards selection identified a ‘selected model’ of physiological and surgical measures in addition to patient and tumour characteristics. Model performance was assessed compared to a ‘basic model’ including only patient and tumour characteristics. Missing data was multiply imputed. Results: Eight hundred forty-six of 10 578 (8.0%) patients died within 90 days of surgery. The selected model included seven preoperative physiological and surgical measures (pulse rate, systolic blood pressure, breathlessness, sodium, urea, albumin, and predicted peritoneal soiling), in addition to the 10 patient and tumour characteristics in the basic model (calendar year of surgery, age, sex, ASA grade, TNM T stage, TNM N stage, TNM M stage, cancer site, number of comorbidities, and emergency admission). The selected model had considerably better discrimination compared to the basic model (C-statistic: 0.824 versus 0.783, respectively). Conclusion: Linkage of disease-specific and treatment-specific datasets allowed the inclusion of physiological and surgical measures in a risk model alongside patient and tumour characteristics, which improves the accuracy of the prediction of the mortality risk for CRC patients having emergency surgery. This improvement will allow more accurate performance monitoring of healthcare providers and enhance clinical care planning.